Literature DB >> 3259610

Phosphorylation of T cell membrane proteins by activators of protein kinase C.

T A Chatila1, R S Geha.   

Abstract

Activation of the enzyme protein kinase C (PKC) plays an important role in T cell activation. We investigated the phosphorylation of CD2, CD3, CD4, CD5, CD7, CD8, CD28 (Tp44), CD43 (sialophorin, gp115), and LFA-1 after incubation of human PBMC with the (PKC) activator PMA. These proteins were chosen for their role in transmembrane signal transduction (CD2, CD3, CD5, CD28, CD43), cell-cell interaction and adhesion (CD2, CD4, CD8, and LFA-1), or involvement in immunodeficiency states (CD43, CD7). CD5, CD7, CD43, and the alpha-chain of LFA-1 were found to be constitutively phosphorylated. PMA induced rapid hyperphosphorylation of CD5, CD7, and CD43, but not of the LFA-1 alpha-chain, and induced the phosphorylation of CD3, CD4, CD8 and of the LFA-1 beta-chain. PMA did not cause the phosphorylation of CD2 and CD28. PMA-induced phosphorylation was partially inhibited by the PKC inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride. Finally, the T cell activator Con A, which binds to the CD3/TCR complex was shown to induce a profile of protein phosphorylation similar to that observed with PMA. We conclude that PKC-mediated phosphorylation of T cell Ag may represent an important regulatory mechanism that governs the process of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA.

Authors:  O C Farokhzad; J M Teodoridis; H Park; M A Arnaout; C S Shelley
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

3.  Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7.

Authors:  Y Costantinides; G Kingsley; C Pitzalis; G S Panayi
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes.

Authors:  T Chatila; E Castigli; R Pahwa; S Pahwa; N Chirmule; N Oyaizu; R A Good; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

6.  Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.

Authors:  C S Shelley; E Remold-O'Donnell; A E Davis; G A Bruns; F S Rosen; M C Carroll; A S Whitehead
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Protein kinase C isotypes theta, delta and eta in human lymphocytes: differential responses to signalling through the T-cell receptor and phorbol esters.

Authors:  C Keenan; A Long; Y Volkov; D Kelleher
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

8.  Structure of the human sialophorin (CD43) gene. Identification of features atypical of genes encoding integral membrane proteins.

Authors:  C S Shelley; E Remold-O'Donnell; F S Rosen; A S Whitehead
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

9.  Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases.

Authors:  J S Nixon; S E Wilkinson; P D Davis; A D Sedgwick; J Wadsworth; D Westmacott
Journal:  Agents Actions       Date:  1991-03

10.  CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex.

Authors:  A A Davies; S C Ley; M J Crumpton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.